AAPCHO Announces One Year Hepatitis B Policy Fellowship - Applications Due March 9, 2009 (Deadline Extended)

January 21, 2009

In the United States, an estimated 2 million people are living with chronic hepatitis B, with a disproportionate impact on the Asian American and Pacific Islander community. It is thought that over 800,000 Asian Americans in total are living with the disease, comprising more than 40 percent of all cases in the United States. Recent studies have
found that 10 percent of foreign-born Asian Americans are chronically infected with hepatitis B.

Approximately 25 percent of people with chronic hepatitis B develop chronic liver disease, cirrhosis or primary liver cancer - this is unnecessary and unacceptable - chronic hepatitis B is a treatable disease. Many are unaware of their condition because hepatitis B can progress without noticeable symptoms. Without awareness, screening and diagnosis, these people are not receiving treatment that could slow the disease, and may unintentionally be exposing others to the hepatitis B virus. The lack of routine screening in Asian American communities in the United States is one of the main reasons why rates of liver cancer are significantly higher in these communities compared to other ethnic groups.

Program Description: The fellowship is a year-long program based in Washington D.C. and will be awarded to a medical, public health, or policy professional who is interested in strengthening the collaboration between key stakeholders and the federal government in order to achieve practical solutions for the disparate impact of hepatitis B on Asian American and Pacific Islanders. Key goals of the fellowship will be:

1) To facilitate collaboration among grassroots efforts, health organizations and governmental entities to advance healthcare policy and practices that are designed to support effective screening, treatment and prevention initiatives for hepatitis B in the Asian American and Pacific Islander community; and

2) To inform and support efforts by the Congressional Asian Pacific American Caucus (CAPAC) members and other Congressional members to adopt a policy platform and legislative agenda that effectively reduces the prevalence of hepatitis B and increases care and treatment programs in heavily impacted communities.

Eligibility: All applicants are required to meet the following criteria:
- Applicants must be a citizen or legal resident of the United States;
- Applicants must be at a mid-career level with at least five years of management responsibility;
- Applicants must have completed a master's degree or doctorate (or the equivalent thereof) in health services research, clinical services(including providers), health administration, health law, health policy or a related discipline such as economics or political science;
- Applicants should have demonstrated expertise in health policy issues,particularly hepatitis B, and track record of informing health policy through research, policy analysis or clinical leadership;

Selection Criteria and Process: Fellows must be able to participate in the program from March 2009 through March 2010 and reside / relocate to the Washington DC metropolitan area. Applications should be submitted to AAPCHO and will be reviewed by a selection committee. Final selection of the fellow will be made in February 2009. A prospective fellow must demonstrate professional experience and competence in hepatitis B advocacy, financing and/or clinical services. Fellows must also demonstrate significant interest in public policy and activities of the Legislative branch and exemplify strong interest in applying hepatitis B field knowledge to crafting and driving targeted policies to reduce the burden of hepatitis B amongst Asian Americans and Pacific Islanders. Fellows must be able to work in a fast-paced environment with minimal supervision, communicate effectively on a wide variety of topics and be able to work cooperatively with a diverse group of individuals and organizations.

Application: Please note that the deadline for receipt of applications for the 2009 fellowship is March 9, 2009. Applications should be submitted electronically to AAPCHO at hepBfellow@aapcho.org and should include the following materials:

- A resume or curriculum vitae providing information about educational background, professional employment and activities, professional publications and presentations, public policy and legislative experience and committee and advisory group appointments, particularly when related to hepatitis B;
- A statement of no more than 750 words addressing the applicant's interests in the fellowship, career goals, contributions the applicant believes he or she can make as a hepatitis B professional to the legislative process and what the applicant hopes to learn from the experience;
- A list of three professional references from the applicant's previous institution(s) or organization(s) who can comment on the applicant's ability to work with the CAPAC and other members of U.S. Congress as a special legislative liaison.

For further questions regarding eligibility or the application process, please contact hepBfellow@aapcho.org or call 510.272.9536 x 103.

Compensation: The fellowship stipend will be up to $75,000 per year plus benefits, including health insurance and dental insurance. The stipend will be based upon years of advanced experience. A portion of the relocation and transportation costs may be covered.


AAPCHO is a national association representing community health organizations dedicated to promoting advocacy, collaboration and leadership that improves the health status and access of Asian Americans, Native Hawaiians, and Pacific Islanders in the United States. Since its inception in 1987, AAPCHO has advocated for policies and programs that improve the provision of health care services that are community driven, financially affordable, linguistically accessible, and culturally appropriate. As a unified voice of its membership, AAPCHO shares its collective knowledge and experiences with policy makers at the national, state, and local levels.